DexCom Downgraded

Cowen & Co. analyst Sara Michelmore downgraded DexCom Inc. (DXCM) after a number of insurance companies said that they will delay reimbursements for DexCom's continuous glucose monitors until at least 2008. Shares of the medical device maker tumbled $2.86 to close at $13.97.